Roche's shares dropped more than 5% on Monday as the ​Swiss drugmaker failed to show that its promising breast cancer drug ...

News, features, and commentary about cancer-related issues ...

By Sneha S K March 9 (Reuters) - Bristol Myers Squibb on Monday said its experimental drug for a rare form of blood cancer ...

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

A Roche Holding AG study of its experimental breast-cancer drug in combination with another treatment failed to meet the ...

March 5 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Johnson & Johnson's treatment for a type of ...

A police force is investigating allegations surrounding breast cancer treatment at a hospital trust. Durham Police is working to establish if any criminal offences were committed in light of concerns ...

Researchers at the University of Gothenburg have identified a protein linked to an increased risk of metastasis and recurrence in lung cancer. The findings are presented in a study published in the ...

In recent years, scientists have discovered that some chemotherapy drugs not only kill cancer cells directly, but at least in some patients, mysteriously also trigger their immune system to attack the ...

It may be best not to go off-script when it comes to breast cancer. Roughly 1 in 8 US women are expected to be diagnosed with invasive breast cancer at some point. It’s the most common cancer in women ...

Surgeon Gareth Honeybone wants wider access to zanidatamab to treat one of the deadliest cancers.

During the Miami Breast Cancer Conference, CURE discussed ADCs with Dr. Kevin Kalinsky.